Your browser doesn't support javascript.
PIKfyve inhibitors against SARS-CoV-2 and its variants including Omicron.
Su, Jingyi; Zheng, Jing; Huang, Wei; Zhang, Yali; Lv, Cairui; Zhang, Baoding; Jiang, Lina; Cheng, Tong; Yuan, Quan; Xia, Ningshao; Zhang, Jianming; Li, Li; Li, Li; Deng, Xianming.
  • Su J; State Key Laboratory of Cellular Stress Biology, Innovation Center for Cell Signaling Network, School of Life Sciences, Xiamen University, 361102, Xiamen, Fujian, China.
  • Zheng J; Xiamen Center for Disease Control and Prevention, 361021, Xiamen, Fujian, China.
  • Huang W; State Key Laboratory of Cellular Stress Biology, Innovation Center for Cell Signaling Network, School of Life Sciences, Xiamen University, 361102, Xiamen, Fujian, China.
  • Zhang Y; State Key laboratory of Molecular Vaccinology and Molecular Diagnostics, National Institute of Diagnostics and Vaccine Development in Infectious Diseases, School of Public Health, Xiamen University, 361102, Xiamen, Fujian, China.
  • Lv C; State Key Laboratory of Cellular Stress Biology, Innovation Center for Cell Signaling Network, School of Life Sciences, Xiamen University, 361102, Xiamen, Fujian, China.
  • Zhang B; State Key Laboratory of Cellular Stress Biology, Innovation Center for Cell Signaling Network, School of Life Sciences, Xiamen University, 361102, Xiamen, Fujian, China.
  • Jiang L; Xiamen Center for Disease Control and Prevention, 361021, Xiamen, Fujian, China.
  • Cheng T; State Key laboratory of Molecular Vaccinology and Molecular Diagnostics, National Institute of Diagnostics and Vaccine Development in Infectious Diseases, School of Public Health, Xiamen University, 361102, Xiamen, Fujian, China.
  • Yuan Q; State Key laboratory of Molecular Vaccinology and Molecular Diagnostics, National Institute of Diagnostics and Vaccine Development in Infectious Diseases, School of Public Health, Xiamen University, 361102, Xiamen, Fujian, China.
  • Xia N; State Key laboratory of Molecular Vaccinology and Molecular Diagnostics, National Institute of Diagnostics and Vaccine Development in Infectious Diseases, School of Public Health, Xiamen University, 361102, Xiamen, Fujian, China.
  • Zhang J; National Translational Research Center, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China.
  • Li L; Xiamen Center for Disease Control and Prevention, 361021, Xiamen, Fujian, China. strlchen@163.com.
  • Li L; State Key Laboratory of Cellular Stress Biology, Innovation Center for Cell Signaling Network, School of Life Sciences, Xiamen University, 361102, Xiamen, Fujian, China. lli@xmu.edu.cn.
  • Deng X; State Key Laboratory of Cellular Stress Biology, Innovation Center for Cell Signaling Network, School of Life Sciences, Xiamen University, 361102, Xiamen, Fujian, China. xmdeng@xmu.edu.cn.
Signal Transduct Target Ther ; 7(1): 167, 2022 05 24.
Article in English | MEDLINE | ID: covidwho-1860337

Full text: Available Collection: International databases Database: MEDLINE Main subject: SARS-CoV-2 / COVID-19 Drug Treatment Topics: Variants Limits: Humans Language: English Journal: Signal Transduct Target Ther Year: 2022 Document Type: Article Affiliation country: S41392-022-01025-8

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: SARS-CoV-2 / COVID-19 Drug Treatment Topics: Variants Limits: Humans Language: English Journal: Signal Transduct Target Ther Year: 2022 Document Type: Article Affiliation country: S41392-022-01025-8